2007
DOI: 10.1002/ijc.23069
|View full text |Cite
|
Sign up to set email alerts
|

Wnt signaling controls radiosensitivity via cyclooxygenase‐2‐mediated Ku expression in head and neck cancer

Abstract: It has been proposed that Wnt signaling pathway may be a key radioprotective mechanism in irradiated cancer cells; however, the specific radioresistance mechanisms remain not to be fully clarified. Here we elucidate a novel signaling pathway of radioresistance in head and neck cancer (HNC) cell lines involving interactions among the Wnt signaling pathway, cyclooxygenase-2 (COX-2) and Ku expression. Activation of the Wnt signaling pathway by (2 0 Z,3 0 E)-6-bromoindirubin-3 0 -oxime (BIO) resulted in bcatenin c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
44
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 56 publications
(44 citation statements)
references
References 26 publications
(40 reference statements)
0
44
0
Order By: Relevance
“…17 This effect is also demonstrated in vivo, in which irradiation causes a drastic loss of ␤-catenin staining in the gastrointestinal epithelium. 41 In contrast to these studies, we found an increase in ␤-catenin protein abundance and transcriptional activity after irradiation in both mouse and human fibroblast cell cultures, as well as during wound healing in vivo.…”
Section: Discussionmentioning
confidence: 83%
See 2 more Smart Citations
“…17 This effect is also demonstrated in vivo, in which irradiation causes a drastic loss of ␤-catenin staining in the gastrointestinal epithelium. 41 In contrast to these studies, we found an increase in ␤-catenin protein abundance and transcriptional activity after irradiation in both mouse and human fibroblast cell cultures, as well as during wound healing in vivo.…”
Section: Discussionmentioning
confidence: 83%
“…The notion that ␤-catenin promotes cell survival after irradiation is supported by studies showing that Wnt ligands promote survival in other cell types after irradiation, for instance in head and neck cancers and in mammary progenitor cells. 15,17 These data suggest that the difference in regulation of ␤-catenin in response to irradiation between different cell types could in part be responsible for variability in the response to irradiation. Because ␤-catenin acts to increase proliferation rate and maintain cell viability, its activation by irradiation in fibroblasts likely acts to make this cell type relatively resistant to irradiation.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Analysis of the molecular and signalling mechanism of resistance of cancer stem/progenitor cells should be important for the development of new therapeutic strategies. Recent studies showed that the Wnt/b-catenin pathway plays a role in radiation and/or chemotherapy resistance of various malignancies such as leukaemia, head and neck tumours, prostate cancer and HCC (Jamieson et al, 2004;Ohigashi et al, 2005;Chang et al, 2008;Yang et al, 2008). In this study, we also showed that activation of Wnt/b-catenin signalling by a specific GSK-3 inhibitor in hepatoma cell lines decreased the susceptibility to IFN-a/5-FU through a reduction in their DNA synthesis inhibitory effects and regulation of cell cycle progression.…”
Section: Discussionmentioning
confidence: 99%
“…[12] The molecular and macromolecular changes that underlie loss of epithelial cell-cell adhesion, loss of apical-basal polarity and loss of epithelial anchorage to the basement membrane have been described for numerous cancers including those of the head and neck. [13] Known EMT biomarkers in HNSCC include cell surface proteins (E-cadherin, N-cadherin), [14][15][16] cytoskeleton proteins (β-catenin, Vimentin), [14,17,18] extracellular matrix proteins (Fibronectin) [19,20] and transcription factors (Snail1). [21,22] The process of EMT has been associated with the gain of stem cell-like properties, [23] with numerous cancer stem cell markers described for head and neck cancers including: CD133, CD44, CD24, ALDH1, ABCG2 and Bmi1.…”
Section: Introductionmentioning
confidence: 99%